Advanced Search
Contact | Corporate | Help

Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

Sponsors:
  • Manhattan Eye, Ear & Throat Hospital
  • Alcon Research
Phases:
  • Phase II
IndicationsAcronym:
  • Severe Diabetic Retinopathy
  • Central Retinal Vein Occlusion
  • Chronic Inflammation
  • Infectious Diseases
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: anecortave acetate
Enrollment:
0

Additional information about NCT00211471.


SourceSolution © 2008-2012